Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications
E Levit, EE Longbrake, SS Stoll - Multiple Sclerosis and Related Disorders, 2022 - Elsevier
The impaired ability to mount an effective immune response to vaccination leaves
immunosuppressed patients at higher risk of severe COVID-19 infection. This retrospective …
immunosuppressed patients at higher risk of severe COVID-19 infection. This retrospective …
Post-vaccination SARS-Cov-2 T-cell receptor repertoires in patients with multiple sclerosis and related disorders
P Algu, N Hameed, T DeAngelis, J Stern… - Multiple Sclerosis and …, 2023 - Elsevier
Background Attenuation in post-vaccination SARS-CoV-2 humoral responses has been
demonstrated in people treated with either anti-CD20 therapies or sphingosine-1-phosphate …
demonstrated in people treated with either anti-CD20 therapies or sphingosine-1-phosphate …
[HTML][HTML] COVID-19 in multiple sclerosis: clinically reported outcomes from the UK multiple sclerosis register
RM Middleton, EM Craig, WJ Rodgers… - Multiple Sclerosis and …, 2021 - Elsevier
Abstract Background: In March 2020, the United Kingdom Multiple Sclerosis Register
(UKMSR) established an electronic case return form, designed collaboratively by MS …
(UKMSR) established an electronic case return form, designed collaboratively by MS …